» Articles » PMID: 16842971

Proton Magnetic Resonance Spectroscopy in Subjects at Risk for Schizophrenia

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2006 Jul 18
PMID 16842971
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

We used proton magnetic resonance spectroscopy (1H MRS) to examine biochemical characteristics of the brain tissue in subjects at risk for schizophrenia. Nineteen participants fulfilling research criteria for an early (n=10) or a late (n=9) at-risk syndrome, 21 patients with full disease according to DSM IV and 31 healthy control subjects were included in the study. Single-voxel 1H MRS was performed in the left frontal lobe, the anterior cingulate gyrus and the left superior temporal lobe. Subjects were followed longitudinally to detect conversion to schizophrenia. We observed a significant reduction of the metabolic ratios NAA/Cr and NAA/Cho in the left frontal lobe and of NAA/Cr in the anterior cingulate gyrus in both at-risk groups and in the schizophrenic patients compared with healthy controls. Those at-risk subjects, who converted to schizophrenia within the observation period, had a higher Cho/Cr and a lower NAA/Cho ratio in the anterior cingulate gyrus compared with non-converters. NAA/Cr did not differ between converters and non-converters. Six at-risk subjects were taking antidepressants, two were taking antipsychotics. There was no difference in any metabolic ratio in any region between at-risk subjects with and without medication. We conclude that the reduction of the neuronal marker NAA in the left prefrontal lobe and the anterior cingulate gyrus may represent a vulnerability indicator for schizophrenia in at-risk subjects, while elevated Cho in the anterior cingulate gyrus may be a predictor for conversion from the prodromal state to the full disease.

Citing Articles

A Review of Potential Neuroimaging Biomarkers of Schizophrenia-Risk.

Mamah D J Psychiatr Brain Sci. 2023; 8(2).

PMID: 37427077 PMC: 10327607. DOI: 10.20900/jpbs.20230005.


Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status.

Yang Y, Smucny J, Zhang H, Maddock R Neuroimage Clin. 2023; 39:103461.

PMID: 37406595 PMC: 10509531. DOI: 10.1016/j.nicl.2023.103461.


N-Acetylaspartate and Choline Metabolites in Cortical and Subcortical Regions in Clinical High Risk Relative to Healthy Control Subjects: An Exploratory 7T MRSI Study.

Mayeli A, Janssen S, Huston C, Rupp J, Sharma K, Moon C Int J Mol Sci. 2023; 24(9).

PMID: 37175389 PMC: 10178465. DOI: 10.3390/ijms24097682.


Modular Functional-Metabolic Coupling Alterations of Frontoparietal Network in Schizophrenia Patients.

Xiang Q, Xu J, Wang Y, Chen T, Wang J, Zhuo K Front Neurosci. 2019; 13:40.

PMID: 30787862 PMC: 6372554. DOI: 10.3389/fnins.2019.00040.


Impaired context processing as a potential marker of psychosis risk state.

Niendam T, Lesh T, Yoon J, Westphal A, Hutchison N, Ragland J Psychiatry Res. 2013; 221(1):13-20.

PMID: 24120302 PMC: 3947990. DOI: 10.1016/j.pscychresns.2013.09.001.